Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,735 | 121,414 | 61,761 | 39,848 | 45,670 |
| Marketable Securities | 28,185 | N/A | N/A | 28,996 | 25,779 |
| Receivables | 5,585 | 2,566 | 1,197 | 1,052 | 1,208 |
| Other current assets | 482 | 587 | 355 | 476 | 524 |
| TOTAL | $111,740 | $126,062 | $65,508 | $71,642 | $74,228 |
| Non-Current Assets | |||||
| PPE Net | 310 | 326 | 343 | 210 | 96 |
| Other Non-Current Assets | 934 | 1,048 | 1,061 | 1,170 | 1,278 |
| TOTAL | $1,244 | $1,374 | $1,404 | $1,380 | $1,374 |
| Total Assets | $112,984 | $127,436 | $66,912 | $73,022 | $75,602 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,162 | 3,963 | 3,380 | 1,999 | 1,785 |
| Accrued Expenses | 11,598 | 10,008 | 9,013 | 9,336 | 7,121 |
| Other current liabilities | 826 | 3,497 | 1,153 | 2,943 | 259 |
| TOTAL | $17,475 | $19,773 | $16,945 | $16,688 | $21,783 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,725 | 32,437 | 12,716 | 13,617 | 940 |
| Deferred Revenues | 1,565 | 1,974 | 1,974 | 1,974 | 1,974 |
| Other Non-Current Liabilities | 2,581 | 2,693 | 1,379 | 1,422 | 3,262 |
| TOTAL | $35,306 | $35,215 | $14,673 | $16,111 | $5,767 |
| Total Liabilities | $52,781 | $54,988 | $31,618 | $32,799 | $27,550 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,374 | 34,361 | 27,130 | 28,809 | 25,808 |
| Common Shares | 34 | 34 | 27 | 26 | 26 |
| Retained earnings | -656,924 | -643,327 | -621,205 | -609,701 | -601,308 |
| Other shareholders' equity | 0 | 0 | 0 | 1 | -1 |
| TOTAL | $60,203 | $72,448 | $35,294 | $40,223 | $48,052 |
| Total Liabilities And Equity | $112,984 | $127,436 | $66,912 | $73,022 | $75,602 |